[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Associazione Italiana per lo Studio del Pancreas\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":130},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,45,68,99],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100495586","italian-registry-chronic-pancreatitis-100495586",false,"NCT05733130","Italian Registry Chronic Pancreatitis","Registro Italiano Pancreatite Cronica","ITARECIPE","Inclusion Criteria:\n\n* Age \\>\u002F= 12 years;\n* Diagnosis \"definite\" or \"probable\" according to the \"M-ANNHEIM\" criteria;\n* First evidence of diagnosis within 12 months of enrolment.\n\nExclusion Criteria:\n\n* Age \\\u003C 12 years;\n* History of known disease with certainty for \\> 12 months.","ALL","12 Years",{"count":20,"type":21},1500,"ESTIMATED","5 Years","OBSERVATIONAL","ITARECIPE is a multicenter national registry designed to study the diagnosis and evolution of Chronic Pancreatitis",[26],"Chronic Pancreatitis",[28,29,30,31],"chronic pancreatitis","surveillance chronic pancreatitis","chronic pancreatitis diagnosis","chronic pancreatitis therapy","RECRUITING","2024-07-10",{"date":35,"type":36},"2024-07-11","ACTUAL",{"date":38,"type":36},"2022-10-10",{"date":40,"type":21},"2027-12-31",{"name":42,"class":43},"Associazione Italiana per lo Studio del Pancreas","OTHER",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":17,"minAge":53,"maxAge":4,"enrollmentInfo":54,"targetDuration":56,"studyType":23,"phases":4,"briefSummary":57,"conditions":58,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":44},"100545396","italian-registry-of-minimally-invasive-pancreatic-surgery-100545396","NCT06381362","Italian Registry of Minimally Invasive Pancreatic Surgery","Italian Registry of Minimally Invasive Pancreatic Surgery (IGOMIPS)","IGOMIPS","Inclusion Criteria:\n\n* Age \\> 18 years;\n* Underwent minimally invasive pancreatic surgery\n\nExclusion Criteria:\n\n* Pregnant woman\n* Minor or unable to give informed consent","18 Years",{"count":55,"type":21},2300,"3 Months","Assess the prevalence of minimally invasive pancreatic surgery in the country and its outcomes",[59],"Pancreatic Surgery","2024-04-22",{"date":62,"type":36},"2024-04-24",{"date":64,"type":36},"2019-02-28",{"date":66,"type":21},"2029-02-28",{"name":42,"class":43},{"id":69,"slug":70,"hasResults":11,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":74,"eligibilityCriteria":75,"healthyVolunteers":11,"sex":17,"minAge":53,"maxAge":76,"enrollmentInfo":77,"targetDuration":4,"studyType":79,"phases":80,"briefSummary":82,"conditions":83,"keywords":85,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":44},"100494962","familial-pancreatic-cancer-prophilation-program-in-italy-100494962","NCT05724992","Familial Pancreatic Cancer PROPHilation Program in Italy","Standardised Genetic Profiling of Subjects Belonging to the Italian Multicenter Registry of Prospective Surveillance of Subjects at Genetic Risk of Pancreatic Cancer","PROPH-ITA","Inclusion Criteria:\n\n* Being enrolled on the IRFARPC registry\n* Having familiarity for pancreatic cancer (according to the IRFARPC criteria, Capurso et al. Dig Liv Dis, 2020)\n* Willingness to participate in saliva-swab-based genetic testing\n\nExclusion Criteria:\n\n\\- Already known genetic mutation","80 Years",{"count":78,"type":21},3000,"INTERVENTIONAL",[81],"NA","The goal of the PROPH-ITA Study is to perform genetic testing in family members of pancreatic cancer patients who may have a genetic predisposition. The subjects belong to the Italian Registry of Families At Risk of Pancreatic Cancer (IRFARPC, #NCT04095195). This investigational study will assess the genetic background of subjects with familiarity with pancreatic cancer only.\n\nParticipants may accept to undergo genetic testing as part of the IRFARPC registry, through a saliva-swab-based 41-gene panel test.\n\nUp to 3,000 participants will be enrolled in this study.",[84],"Candidates for Hereditary Pancreatic Cancer Testing",[86,87,88,89,90],"Pancreatic Cancer","Pancreatic Cancer familiarity","Genetic profiling","Genetic predisposition","Pancreatic Cancer surveillance","2023-02-13",{"date":93,"type":36},"2023-02-15",{"date":95,"type":36},"2022-12-20",{"date":97,"type":21},"2028-12-20",{"name":42,"class":43},{"id":100,"slug":101,"hasResults":11,"nctId":102,"briefTitle":103,"officialTitle":104,"acronym":105,"eligibilityCriteria":106,"healthyVolunteers":11,"sex":17,"minAge":53,"maxAge":76,"enrollmentInfo":107,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":109,"conditions":110,"keywords":118,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":122,"lastUpdatePostDateStruct":123,"startDateStruct":125,"completionDateStruct":127,"leadSponsor":129,"locationsCount":5},"100369811","registry-of-subjects-at-risk-of-pancreatic-cancer-100369811","NCT04095195","Registry of Subjects at Risk of Pancreatic Cancer","Italian Registry of Families At Risk of Pancreatic Cancer","IRFARPC","Inclusion Criteria to enter the registry:\n\n* individuals with at least two relatives suffering from pancreatic cancer, with at least 1 first-degree and until the third-degree\n* subjects with known genetic mutation of BRCA2, BRCA1, p16, PALB2 with at least 1 first- or 2nd-degree relative suffering from pancreatic cancer\n* subjects suffering from FAMMM Syndrome\n* subjects suffering from Peutz-Jeghers Syndrome\n* subjects suffering from PRSS-1- or CFTR- or SPINK-1- related pancreatitis\n* subjects suffering from Lynch syndrome with at least 1 first- or 2nd-degree relative suffering from pancreatic cancer\n\nInclusion criteria to join the \"radiologic follow-up\":\n\n* 45 years or 10 years younger than the youngest index case of pancreatic cancer in the family for familial cases\n* 40 years or 5 years younger than the youngest index case of pancreatic cancer for subjects suffering from hereditary\u002Fgenetic pancreatitis, Lynch syndrome, or carrying a known BRCA 1\u002F2, PALB2, p16 genetic mutation with familiarity for pancreatic cancer\n* 30 years for subjects suffering from FAMMM, Peutz-Jeghers syndrome\n\nExclusion Criteria:\n\n\\- pregnancy",{"count":108,"type":21},1000,"IRFARPC is a multicenter national registry designed to study the diagnosis and predisposing factors of subjects with an inherited increased risk for pancreatic cancer.",[111,112,113,114,115,116,117],"Familial Pancreatic Cancer","BRCA1 Mutation","BRCA2 Mutation","Lynch Syndrome","FAMMM - Familial Atypical Mole Malignant Melanoma Syndrome","Hereditary Pancreatitis","Peutz-Jeghers Syndrome",[111,119,114,120,121],"BRCA Mutation","Screening pancreatic cancer","Surveillance pancreatic cancer","2023-01-12",{"date":124,"type":36},"2023-01-13",{"date":126,"type":36},"2019-08-20",{"date":128,"type":21},"2045-09-20",{"name":42,"class":43},""]